CHELSEA THERAPEUTICS INTERNATIONAL, LTD. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/070842e9-c76b-455f-a466-bfb3eaa36c99/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-239.6M | 2002-04-03 – 2014-03-31 | evidence 0001144204-14-029111 |
| FY 2012 | $-219.0M | 2002-04-03 – 2013-03-31 | evidence 0001144204-13-025705 |
| FY 2011 | $-198.9M | 2002-04-03 – 2012-03-31 | evidence 0001193125-12-200720 |
| FY 2010 | $-37.3M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-101178 |
| FY 2009 | $-25.8M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-101178 |
| FY 2008 | $-35.1M | 2008-01-01 – 2008-12-31 | evidence 0001193125-12-101178 |
| FY 2007 | $-15.1M | 2007-01-01 – 2007-12-31 | evidence 0001193125-12-101178 |
| FY 2006 | $-8.7M | 2006-01-01 – 2006-12-31 | evidence 0001193125-12-101178 |
| FY 2005 | $-7.9M | 2005-01-01 – 2005-12-31 | evidence 0001193125-12-101178 |
| FY 2004 | $-3.0M | 2004-01-01 – 2004-12-31 | evidence 0001193125-12-101178 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. — all facts · Operating Income